News Flash >

Women's Health

 

Col1a1 Gene Alleles Associate with the risk of Bone Loss

(Osteoporosis - February 20, 2003)


"Allele frequencies of the G --> T polymorphism at the regulatory region of the Col1a1 gene in the population of the northwestern Russia (control group) and in osteoporotic patients were estimated by the RFLP method based on PCR-mediated site-directed mutagenesis," researchers in Russia reported.

"Three patient groups with radiologically confirmed osteoporosis were examined. Group 1 consisted of 64 patients with severe osteoporosis complicated by fractures (SO); group 2 included 15 children with idiopathic osteoporosis (IO); and group 3 consisted of 98 women with postmenopausal osteoporosis developed at the background of estradiol-deficiency state (PMO)," wrote M.V. Moskalenko and colleagues, Russian Academy of Science, Ott Institute for Obstetrics and Gynecology.

"The frequency of functionally defective alleles in the control group was 16.7%. It was statistically different from that in the SO patients (48.4%) (p < 0.01) and in the IO children (40%) (p < 0.01). The frequency of alleles in the PMO patients constituted 23% and it was similar to that in the control group (p > 0.05)."

"Analysis of the Col1a1 alleles provides early detection of the individuals with hereditary predisposition to osteoporosis and prophylaxis of the disease at the presymptomatic stage," researchers advised.

Moskalenko and colleagues published their study in Russian Journal of Genetics (Analysis of association of the Col1a1 gene alleles with the risk of osteoporosis. Russ J Genet, 2002;38(12):1443-1446).

The contact person for this report is M.V. Moskalenko, Russian Academy of Science, Ott Institute for Obstetrics and Gynecology, St. Petersburg 199034, Russia.

To subscribe to the Russian Journal of Genetics, contact the publisher: Kluwer Academic, Plenum Publishing, 233 Spring St., New York, NY 10013, USA.

The information in this article comes under the major subject areas of Genomics and Genetics, Hereditary Disease, and Osteoporosis. This article was prepared by Women's Health Weekly editors from staff and other reports.

©Copyright 2003, Biotech Week via NewsRx.com & NewsRx.net

This story has been adapted from a news release issued by NewsRx.com & NewsRx.net